Saigusa et al. studied 241 patients with CRC and demonstrated that serum IL-13 levels were significantly lower in patients with advanced stage, and low IL-13 levels in the serum was significantly associated with poorer prognosis [63]. The gene discussed is IL13; the disease is colorectal carcinoma.